ECS Botanics secures $4.5 million medicinal cannabis supply agreement with Alivio Spolka July 25, 2021 SYDNEY, AUSTRALIA: ECS Botanics Holdings has entered into a five year agreement with Polish company Alivio Spolka ZO. for the supply of medicinal cannabis…
Kanabo signs medicinal cannabis production agreement March 9, 2021 LONDON: Kanabo Group (LON: KNB) has signed a production and supply agreement with PharmaCann Polska under which PharmaCann will supply cartridges containing Kanabo’s proprietary…
Wellfully joins forces with Dolce Cann Global on medicinal cannabis product development December 21, 2020 SYDNEY: Wellfully Limited will engage in collaboration with NSW-based Dolce Cann Global Ltd Pty to develop cannabinoid products using its patented drug delivery system….
MGC Pharmaceuticals completes acquisition of Australian Medicinal Cannabis Clinics November 23, 2020 SYDNEY: MGC Pharmaceuticals Ltd announced completion of the 100% acquisition of the operating telehealth clinic business assets, data and intellectual property of Medicinal Cannabis…
Damian Wood hired Director of medicinal cannabis production at ECS Botanics October 29, 2020 SYDNEY: ECS Botanics Holdings Ltd announced that Mr Damian Wood has joined the company as Director of Medicinal Cannabis Production. Mr Wood joins ECS…
Emriya to help commercialise and regulatory acceptance of Zelira’s medicinal cannabis products September 30, 2020 PERTH: Emyria Limited has signed an agreement with Zelira Therapeutics to collect data from patients treated with insomnia drug Zenivol through Emyria’s specialist clinical…
MGC signs distribution agreement signed with UK medicinal cannabis provider LYPHE August 14, 2020 PERTH: MGC Pharmaceuticals Ltd, a European bio-pharma company, has signed distribution agreement for MGC Pharma’s EU GMP cannabinoid medicines with leading United Kingdom medical…
MGC Pharma signed binding term sheet to acquire Medicinal Cannabis Clinic July 20, 2020 PERTH: MGC Pharmaceuticals Ltd, a European based bio-pharma company has signed a binding term sheet with Cannvalate Pty Ltd (CVL) to acquire 100% of…
Australia-wide medicinal cannabis study commenced July 16, 2020 SYDNEY: Bod Australia Limited has commenced an Australia-wide, multi-clinic, open-label observational study into the effectiveness of its medicinal cannabis range, MediCabilis, for indications including…
iX Biopharma inks agreement to supply medicinal cannabis wafer to the Australian market April 29, 2020 SINGAPORE: Specialty pharmaceutical company iX Biopharma Ltd announced that its wholly-owned subsidiary, iX Syrinx has formalised a supply agreement with Cannatrek Medical Pty Ltd,…